During the Eighty-Sixth Annual Meeting of the American Public Health Association, we presented our original work on a blood test and a skin test for the detection of cancer in man (1,2). Both of these approaches are based on definite immunologic principles. The blood test detects cancer antigens in the serum of patients by means of the Schultz-Dale procedure in which a sensitized guinea-pig uterine segment is used as the indicator of antigen-antibody reactions (3)(4)(5)(6). In the skin test, the skin of the subject to be tested is used as the site for antigen-antibody reactions following the intradermal injection of polysaccharideantibody complexes, the source of the antibodies being the serum of the subject. This particular approach became possible following our findings that pointed to the polysaccharide-like behavior of cancer antigens (7). Evidence has been presented previously covering the immunologic nature of the skin test (8).The results of our tumor skin test (T.S.T.) performed on 191 subjects (as reported earlier in our first series) demonstrated that this technique is a useful screening procedure for all types of tumor. It was found that the results were positive in all cases of early localized carcinoma, in 85 per cent of carcinomas with local extension, and in 60 per cent of metastatic carcinomas. They were also positive in all cases of solid benign tumors and in 67 per cent of cystic benign tumors. The findings were positive in 31 per cent of normal subjects, but in only 10 per cent of patients with nontumorous diseases. This paper reports confirmatory results obtained with. the tumor skin test in two new series of 332 additional cases (both patients and normal subjects). A new modification of the T.S.T., using trypsinized serum, was introduced in the third series. This modification has markedly increased the sensitivity of the T.S.T. as a screening procedure for all tumors.
METHODSThe details covering preparation of the polysaccharide antigens, the method of testing, and the recording of results have been previously published (2,7,8). Briefly, homogenates (20 per cent by weight) from three types of tumors were used: carcinoma, fibrosarcoma and lymphoma. These homogenates were centrifuged at -5°C. and the sediments obtained between 3,000 to 10,000 rpm were collected. The sediments were brought back to the original volume with isotonic sodium chloride, and used for extraction of sensitizing substances (S.S.) with heat (100°C.) and alkali.